Medivation Inc. buy melinda
Start price
03.03.13
/
50%
€17.65
Target price
03.09.13
€19.00
Performance (%)
19.95%
End price
03.09.13
€21.17
Summary
This prediction ended on 03.09.13 with a price of €21.17. The BUY prediction by melinda finished with a performance of 19.95%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Medivation Inc. | - | - | - | - |
iShares Core DAX® | -3.935% | -3.998% | 11.192% | 10.824% |
iShares Nasdaq 100 | -3.608% | -9.386% | 22.243% | 34.145% |
iShares Nikkei 225® | -4.513% | -8.017% | 5.961% | 2.360% |
iShares S&P 500 | -2.607% | -4.265% | 21.865% | 36.823% |
Comments by melinda for this prediction
In the thread Medivation Inc. diskutieren
schwere Krankheiten Behandlung
Medivation Inc. biopharmazeutische in Zusammenarbeit mit Pfizer über Krankheiten (alzh / Prostata) bekannt
(Laufzeit überschritten)